Pharmaceutical Technology

JUNE 9, 2023

Novaliq medical science and regulatory affairs vice-president Sonja Krösser stated: “We are proud that the FDA approved VEVYE. The safety and efficacy of VEVYE were assessed in a total of 1,369 patients with dry eye disease, of which 738 received VEVYE.

Food and Drug Administration 98

Food and Drug Administration FDA Medical science Food 98

European Pharmaceutical Review

DECEMBER 12, 2022

“Dapagliflozin has been clinically shown to reduce hospitalisations and cardiovascular deaths in heart failure,” commented Dr John McMurray, Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK. “[The] Overall, serious AEs, including death, were reported in 43.5

Transportation 105

Transportation Medical science Safety Patients 105

Referral MD

FEBRUARY 28, 2025

While medical science advances, too many clinics still rely on cumbersome paperwork. This improves patient safety and also ensures compliance with regulations such as HIPAA. We live in a world of instant communication and on-demand services. Whats the solution to such an age-old problem?

Healthcare 52

Healthcare Healthcare Patients Electronics 52

European Pharmaceutical Review

FEBRUARY 22, 2023

Studies show that persistence and adherence are generally better for oral medications compared with injections. Importantly, we believe the safety, reliability, and pharmacokinetic data that we collected through both parts of the Phase I study support the initiation of a Phase II trial of RT-102 in osteoporosis,” Hashim said.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Safety Pharmaceutical 105

European Pharmaceutical Review

DECEMBER 28, 2023

These efficacy results, combined with the safety profile that allows patients to complete their treatment regimen, are extremely encouraging. The majority of patients experienced only mild to moderate treatment-related adverse events, confirming a well-manageable safety profile. later acquired by Eli Lilly and Company.

Food and Drug Administration 84

Food and Drug Administration Patients Safety Medical science 84

European Pharmaceutical Review

AUGUST 15, 2024

Second generation BTKi, acalabrutinib, was designed to be more specific against the target to mitigate some of the toxicities associated with ibrutinib and has demonstrated an improved safety profile in head-to-head clinical trial ELEVATE-RR (acalabrutinib vs ibrutinib) but with similar efficacy (non-inferiority trial with hazard ratio (HR)=1.0).

Safety 52

Safety Patients Medical Medicine 52

Pharmaceutical Representative Training

JANUARY 11, 2021

Pharmacology is the science of medications and the role they play in the body. Being able to describe a drug’s mechanism of action (how it works), its efficacy (how effective it is) and its safety profile, are important to providing HCPs with a fair, balanced message. Pharma Sales Rep Salary & Perks.

Pharmaceutical Sales 52

Pharmaceutical Sales Pharma sales reps Sales Pharmaceutical 52